2017 World HIV/AIDS Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

March 2017 | 292 pages | ID: WC63D4F2A00EN
Venture Planning Group

Abstracts

The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:

• Hospitals
• Public Health Labs
• Commercial/Private Labs
• Blood Banks
• Physician Offices
• Ambulatory Care Centers

For each country, in addition to the test volume and sales projections, the report presents the sales and market share estimates for major suppliers of AIDS tests.Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies profiles leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 292 pages and 36 tables

Contents

1. INTRODUCTION

II. WORLDWIDE TEST OVERVIEW, TECHNOLOGIES AND 1NSTRUMENTATION

A. Background, Diagnostic Tests, 5accines and Drugs
B. 1nstrumentation Review: Operating Characteristics, Features and Selling Princes of Leading 1nfectious Disease
Automated and Semi-automated Analyzers
C. Emerging 1nfectious Disease Diagnostic Technologies
  1. MOLECULAR D1AGNOST1CS
  2. MONOCLONAL ANT1BOD1ES
  3. 1MMUNOASSAYS
  4. D1FFERENT1AL L1GHT SCATTER1NG
  5. 1NFORMAT1ON TECHNOLOGY
  6. ART1F1C1AL 1NTELL1GENCE
  7. L1POSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. D1AGNOST1C 1MAG1NG
  11. GEL M1CRODROPLETS
  12. OTHERS
D. Personal Testing

III. COUNTRY ANALYSES: SALES AND 5OLUME FORECASTS

IV. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. 1nstrumentation
B. Reagent Kits and Test Systems/Panels
C. 1nformation Technology
D. Auxiliary Products

V. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

VI. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher/Life Technology
Wallac/PE
Wako